Navigation Links
Steroids to treat asthma: How safe are they?
Date:2/23/2011

This release is available in French.

Children experiencing an asthma attack who are treated with a short burst of oral steroids may have a transient depression of immune response according to a new study led by Universit de Montral. These findings, published in this month's issue of Pediatric Allergy, Immunology and Pulmonology, have implications for asthmatic children who have flare-ups and who may be exposed to new contagious diseases.

"There is no question that the administration of corticosteroids reduces the risk and duration of hospital admission in children with acute asthma remain the most effective treatment for moderate and severe asthma exacerbations," says first author Francine M. Ducharme, a Universit de Montral professor and paediatrician and researcher at the Sainte-Justine University Hospital Research Center. "However, the safety profile of these medications continues to raise concerns among parents and physicians. New concerns over their possible impact on the immune system stem from rare reports linking or severe chickenpox infections linked with corticosteroid administration."

Reduced immune response to new triggers

Ducharme and colleagues evaluated the immune response of children aged 3 to 17 years, who had arrived at the emergency department (ED) with an asthma attack. All subjects were given immune triggers (known as antigens) and the immune response between those who received corticosteroids versus those who did not were compared.

"Several corticosteroid-treated children had a significantly lower immune response, as measured by the amount of antibody produced, than non-treated kids," says Ducharme.

Reduced immunity only transient

Children enrolled in the study were revaccinated with the antigen five weeks following their initial ED visit. Comparable immune responses were measured in children exposed to oral corticosteroids and not exposed to corticosteroids.

"These findings indicate there is a transient, not sustained, immune suppression in some children exposed to a new antigen at the same time as a corticosteroid administration," says Ducharme.

"In summary, our finding suggest a transient immune suppression occurs in some children who are concomitantly exposed to a new antigen and corticosteroids during an asthma attack, with a recovery within six weeks."

"Given the high frequency of use of these drugs over the past 20 years, the very rare occurrence of severe infectious disease is reassuring and would suggest that the window of risk is very small and only applies to exposure to a new antigen. However, before prescribing oral corticosteroids, it would appear prudent to systematically enquire about recent exposure to chickenpox in children who did not have chickenpox or the vaccine," adds Ducharme. Moreover, all children with asthma who have not had chickenpox should be vaccinated for this condition.

About asthma

The diagnosis of asthma, which is a chronic inflammatory disease of the lungs, has been significantly on the rise over the last few decades. In 2009, asthma caused approximately 250,000 deaths globally. However, with proper treatment, including the administration of inhaled bronchodilators and corticosteroids, all children with asthma can lead a normal life.

Corticosteroids are anti-inflammatory drugs and are used in asthma to reduce swelling. Strong scientific evidence shows that the use of these medications in patients with moderate to severe acute asthma significantly reduces the rate of hospitalizations and, if admitted, the length of stay in hospital. Consequently, these drugs are and should remain the cornerstone of the treatment of an acute asthma exacerbation.


'/>"/>

Contact: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert

Related medicine news :

1. Inhaled steroids increase diabetes risk, say Lady Davis Institute researchers
2. IV Steroids May Be Overkill in COPD Patients
3. Fountain of youth steroids could protect against heart disease
4. Study finds post-transplant patients off steroids have fewer cardiovascular events
5. Steroids Could Harm Hearts Pumping Ability
6. Nanotechnology may lead to new treatment of liver cancer
7. Racial and ethnic minority adolescents less likely to receive treatment for major depression
8. Specialized blood plasma treatment does not improve rotator cuff healing, study finds
9. New Eye Treatment May Save Preemies Sight
10. Smoking during radiation treatments reduces chance of overall survival
11. Research presented at 2011 GU Cancers Symposium highlights advances in treatment of prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... ARI Network Services, Inc. (NASDAQ: ARIS) announced today ... websites for its network of more than 650 U.S.-based dealers. Rhino, a member of ... rotary and flail mowers and cutters, rear blades, post hole diggers, pasture renovators, tillers, ...
(Date:3/29/2017)... , ... March 30, 2017 , ... CHARM CITY RUN ... Run has announced that Mercy Medical Center will serve as the official title sponsor ... region. On Sunday, June 25, 2017, thousands of women will walk or run the ...
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs sold 300 bottles ... AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these results while doing ... an over the counter heart healthy drink, can reduce Arterial Plaque, Lower Blood ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... as it continues developing an ANSI-approved, consensus-based American National Standard for Good ... to publish the first ANSI-approved GMP standard for dietary supplements this spring, ...
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an important ... 2017, at 1:00 PM ET. A recording of the webinar will also be made ... , Home health and hospice companies are still popular targets for healthcare investors. This ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... AMSTERDAM , March 29, 2017   ... global leader in health technology, and PathAI, a ... are collaborating with the aim to develop solutions ... diagnosis of cancer and other diseases. The partnership ... pathology, enabling this form of artificial intelligence to ...
(Date:3/29/2017)... Michigan , USA, March 29, 2017 ... Company that Cares by People magazine, in partnership with ... of 50 companies on the list. This list highlights ... that have succeeded in business while also demonstrating respect, ... the environment.  To determine the companies ...
(Date:3/29/2017)... , March 29, 2017 On March 28, the ... treat adult patients with relapsing forms of multiple sclerosis ... the first drug approved by the FDA for PPMS. ... care professional.  "Multiple sclerosis can have ... Billy Dunn , M.D., director of the Division of ...
Breaking Medicine Technology: